There’s more upside for biotech even after 24% gains in two months By: MarketWatch December 12, 2019 at 13:41 PM EST Seven biotech stocks to consider buying. Read More >> Related Stocks: Acadia Pharmaceutica Amarin Corp ADR Amgen Arqule Inc Astellas Pharma Inc Astrazeneca Plc ADR Biogen Idec Boundless Bio Inc Crispr Therapeutics Ag Exact Sciences Cor Gilead Sciences Medicines Company Merck & Co Nasdaq Biotechnology Ishares ETF Novartis Ag ADR S&P Biotech SPDR Sage Therapeutic Com Sanofi-Aventis S.A. ADR Swedish Orphan Biovitrum Ab Synthorx Inc Vertex Pharmaceuticals